Bienville Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Bienville Capital Management's DGX Position: Q4 2023 in Review
Bienville Capital Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,000 shares — an estimated $244K sold.
Bienville Capital Management first reported a position in DGX in Q2 2017 and held it in 22 quarters. The position peaked at $444K in Q2 2020. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.
- Bienville Capital Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
- Bienville Capital Management sold 2,000 Quest Diagnostics shares in Q4 2023, an estimated $244K.
- Bienville Capital Management first reported a position in Quest Diagnostics in Q2 2017 and held it in 22 quarters.
- Bienville Capital Management's Quest Diagnostics position peaked at $444K in Q2 2020.
- 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.
Based on Bienville Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.